October 10, 2011
Korosho announced revisions in the precautions section of the package insert for the anticoagulant dabigatran etexilate methanesulfonate (brand name: Prazaxa Capsules 75 mg and 110 mg) in Pharmaceuticals and Medical Devices Safety Information No. 283 published on September 28. Prazaxa...read more